Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.51 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | BMP1 | P13497 | 1/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1636628 | 1.00 | CA2 (0.53) | CA2MAPK1CA1FOLH1NAALAD2 | |
| SCHEMBL6413427 | 1.00 | CA2 (0.53) | CA2MAPK1CA1FOLH1NAALAD2 | |
| SCHEMBL6413425 | 1.00 | CA2 (0.53) | CA2MAPK1CA1FOLH1NAALAD2 | |
| SCHEMBL936053 | 0.89 | NOD1 (0.54) | FOLH1NAALAD2RIMKLANOD1PLA2G2C | |
| SCHEMBL27625153 | 0.89 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL26352059 | 0.88 | FOLH1 (0.57) | CA2CA1FOLH1NAALAD2RIMKLA | |
| SCHEMBL9981032 | 0.88 | NOD1 (0.55) | FOLH1NAALAD2RIMKLANOD1 | |
| SCHEMBL29849120 | 0.85 | USP2 (0.50) | CA2MAPK1CA1BMP1PLA2G2C | |
| SCHEMBL16240658 | 0.84 | LMNA (0.56) | CA2CA1MEN1KMT2A | |
| SCHEMBL16240312 | 0.84 | TDP1 (0.47) | CA2MAPK1CA1BMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | claimed |
| EP-1827367-A1 | ANTIPERSPIRANT OR DEODORANT COMPOSITIONS | Unilever Plc (GB) | 2007-09-05 | — | — | EP | claimed |
| WO-2006066704-A1 | ANTIPERSPIRANT OR DEODORANT COMPOSITIONS | UNILEVER PLC (GB) | 2006-06-29 | — | — | WO | claimed |
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | disclosed |
| EP-3498255-B1 | TRANSPARENT SOLID COMPOSITION | SHISEIDO CO LTD (JP) | 2024-09-25 | — | — | EP | disclosed |
| US-20240216240-A1 | Oily Liquid Cosmetic | JO COSMETICS CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| EP-4366679-A1 | EMULSION ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2024-05-15 | — | — | EP | disclosed |
| EP-4366682-A1 | METHOD OF MANUFACTURE OF ANTIPERSPIRANT SALTS | Unilever IP Holdings B.V. (NL) | 2024-05-15 | — | — | EP | disclosed |
| US-20240091125-A1 | ANTIPERSPIRANT COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER | 2024-03-21 | — | — | US | disclosed |
| US-20240000690-A1 | ANTIPERSPIRANT COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER | 2024-01-04 | — | — | US | disclosed |
| EP-4255382-A1 | ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2023-10-11 | — | — | EP | disclosed |
| EP-2071975-A2 | Antiperspirant or deodorant products comprising labile agent and pigments | Unilever PLC (GB) | 2009-06-24 | — | — | EP | disclosed |
| EP-1827367-A1 | ANTIPERSPIRANT OR DEODORANT COMPOSITIONS | Unilever Plc (GB) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007093286-A2 | GODET AND DISPENSER | UNILEVER PLC (GB) | 2007-08-23 | — | — | WO | disclosed |
| US-7244419-B2 | A trialkyltriamide of an aspartic or glutamic acid residue; oil-based cosmetics with improved gellation, strength and transparency | AJINOMOTO CO., INC. (JP) | 2007-07-17 | — | — | US | disclosed |
| WO-2006066704-A1 | ANTIPERSPIRANT OR DEODORANT COMPOSITIONS | UNILEVER PLC (GB) | 2006-06-29 | — | — | WO | disclosed |
| CN-1784208-A | stick composition | UNILEVER PLC (GB) | 2006-06-07 | — | — | CN | disclosed |
| CN-1784209-A | stick composition | UNILEVER PLC (GB) | 2006-06-07 | — | — | CN | disclosed |
| US-20060078581-A1 | Oily gel composition | AJINOMOTO CO., INC. (JP) | 2006-04-13 | — | — | US | disclosed |
| WO-2000005434-A1 | METHOD OF INHIBITING DARKENING, BLACKENING OR TARNISHING OF MAGNESIUM AND MAGNESIUM ALLOYS AND COMPOSITIONS THEREFOR | SOLUTIA INC. (US) | 2000-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000690-A1 | ANTIPERSPIRANT COMPOSITIONS | LNPEP, PLOD3, CNDP2 | CA2 3347/4885MAPK1 4123/4885CA1 4271/4885 |
| US-20060078581-A1 | Oily gel composition | DGKG, DGKA, DGKK | CA2 2126/4885MAPK1 3216/4885CA1 1155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.